Delisting risk
Aethlon Medical (AEMD)
Developer of the investigational Hemopurifier for virus and extracellular-vesicle removal.
$1.71
Pre-market−0.13 (−7.07%)
At close$1.84(0.00%)
Something off on this page? Send us feedback.
Breakdown13F · 13D/G · Form 4
| Institutions12 holders · as of Mar 31, 2026 | 2.69% | 14.2K shares | |
| Insiders4 holders · as of Jul 1, 2026 | 3.42% | 18.0K shares | |
| Otherremainder | 93.89% | 494.5K shares |
526.7K company shares as of Aug 22, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing
Two share counts disagree (711.1K in the company's Sep 3, 2026 report, 526.7K elsewhere); stakes use the report.
Institutions13F, as of Mar 31, 2026
12 holders · 70.8K shares · 6 new positions · 6 increased · 0 reduced · 2 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Geode Capital Management, LLC | 24.4K | 4.63% | +24.4Knew | May 15, 2026 |
| Ikarian Capital, LLC | 14.4K | 2.73% | 0 | May 15, 2026 |
| Shay Capital LLC | 14.1K | 2.68% | +14.1Knew | May 15, 2026 |
| XTX Topco Ltd | 13.3K | 2.53% | +13.3Knew | May 15, 2026 |
| Morgan Stanley | 2.0K | 0.39% | 0 | May 15, 2026 |
| Tower Research Capital LLC (TRC) | 1.6K | 0.31% | +1.6Knew | May 15, 2026 |
| UBS Group AG | 895 | 0.17% | +895new | May 5, 2026 |
| Group One Trading, L.P. | 14 | 0.00% | 0 | May 13, 2026 |
Ownership statements13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Armistice Capital, LLC | 9.99% | 13G | May 15, 2025 ↗ | |
| Mitchell P. Kopin | 7.70% | 13G | Sep 10, 2025 ↗ |
Insider tradesForm 4
Latest trades
No open-market trades in the last 12 months.
CongressHouse and Senate disclosures
Not reported.
